Contact information
+44 (0)1865 857298
Fax +44 (0)1865 857299
Research groups
Colleges
DPhil Supervisor Profile
Mark McCarthy
MA, MB, BChir, MD, FRCP, FRSB, FMedSci
Robert Turner Professor of Diabetic Medicine
My group brings together large-scale genetic, genomic and clinical data relevant to type 2 diabetes and related conditions, and then uses it to explore mechanisms.
Key publications
-
Genome-wide associations for birth weight and correlations with adult disease.
Journal article
Horikoshi M. et al, (2016), Nature, 538, 248 - 252
-
The genetic architecture of type 2 diabetes.
Journal article
Fuchsberger C. et al, (2016), Nature, 536, 41 - 47
Recent publications
-
Developing a network view of type 2 diabetes risk pathways through integration of genetic, genomic and functional data.
Journal article
Fernández-Tajes J. et al, (2019), Genome Med, 11
-
The Genetic Basis of Metabolic Disease
Journal article
Barroso I. and McCarthy MI., (2019), Cell, 177, 146 - 161
-
The Early Growth Genetics (EGG) and EArly Genetics and Lifecourse Epidemiology (EAGLE) consortia: design, results and future prospects.
Journal article
Middeldorp CM. et al, (2019), Eur J Epidemiol
-
Variation in the Plasma Membrane Monoamine Transporter (PMAT, Encoded in SLC29A4) and Organic Cation Transporter 1 (OCT1, Encoded in SLC22A1) and Gastrointestinal Intolerance to Metformin in Type 2 Diabetes: An IMI DIRECT Study.
Journal article
Dawed AY. et al, (2019), Diabetes Care
-
Dissecting features of epigenetic variants underlying cardiometabolic risk using full-resolution epigenome profiling in regulatory elements.
Journal article
Allum F. et al, (2019), Nat Commun, 10
ORCID
0000-0002-4393-0510